DK2860256T3 - Process for Preparation of L-Amino Acids - Google Patents
Process for Preparation of L-Amino Acids Download PDFInfo
- Publication number
- DK2860256T3 DK2860256T3 DK14186238.3T DK14186238T DK2860256T3 DK 2860256 T3 DK2860256 T3 DK 2860256T3 DK 14186238 T DK14186238 T DK 14186238T DK 2860256 T3 DK2860256 T3 DK 2860256T3
- Authority
- DK
- Denmark
- Prior art keywords
- gene
- acetate
- seq
- lysine
- promoter
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 48
- 150000008575 L-amino acids Chemical class 0.000 title claims description 25
- 238000002360 preparation method Methods 0.000 title description 13
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 138
- 239000004472 Lysine Substances 0.000 claims description 83
- 108090000623 proteins and genes Proteins 0.000 claims description 76
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 62
- 230000035897 transcription Effects 0.000 claims description 58
- 238000013518 transcription Methods 0.000 claims description 58
- 235000019766 L-Lysine Nutrition 0.000 claims description 57
- 230000014509 gene expression Effects 0.000 claims description 46
- 108020004705 Codon Proteins 0.000 claims description 42
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 39
- 239000002773 nucleotide Substances 0.000 claims description 39
- 125000003729 nucleotide group Chemical group 0.000 claims description 39
- 238000004519 manufacturing process Methods 0.000 claims description 36
- 238000011144 upstream manufacturing Methods 0.000 claims description 31
- 244000005700 microbiome Species 0.000 claims description 28
- 239000004473 Threonine Substances 0.000 claims description 24
- 229960002898 threonine Drugs 0.000 claims description 24
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 12
- 210000000349 chromosome Anatomy 0.000 claims description 12
- 101710088194 Dehydrogenase Proteins 0.000 claims description 7
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims description 6
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 108010063272 UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase Proteins 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 description 57
- 239000012634 fragment Substances 0.000 description 54
- 101150015189 aceE gene Proteins 0.000 description 53
- 108020004414 DNA Proteins 0.000 description 52
- 239000013598 vector Substances 0.000 description 43
- 108091008146 restriction endonucleases Proteins 0.000 description 36
- 101150094017 aceA gene Proteins 0.000 description 35
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 26
- 235000018977 lysine Nutrition 0.000 description 26
- 238000012258 culturing Methods 0.000 description 24
- 101150043597 murE gene Proteins 0.000 description 23
- 101150011371 dapA gene Proteins 0.000 description 21
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 18
- 101150108780 pta gene Proteins 0.000 description 18
- 101150063051 hom gene Proteins 0.000 description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 15
- 229910052799 carbon Inorganic materials 0.000 description 15
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 12
- 238000010367 cloning Methods 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000003313 weakening effect Effects 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000013611 chromosomal DNA Substances 0.000 description 10
- 239000013587 production medium Substances 0.000 description 10
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 9
- 101150072448 thrB gene Proteins 0.000 description 9
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
- 108700026244 Open Reading Frames Proteins 0.000 description 8
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 230000002759 chromosomal effect Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 7
- 101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 7
- 101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 6
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 6
- 101150000233 ORF4 gene Proteins 0.000 description 6
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 6
- 229940009098 aspartate Drugs 0.000 description 6
- 101150070136 axeA gene Proteins 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 241000186216 Corynebacterium Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- 230000000392 somatic effect Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 4
- 108010092060 Acetate kinase Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 4
- 108020003285 Isocitrate lyase Proteins 0.000 description 4
- 239000007836 KH2PO4 Substances 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 description 4
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 4
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 4
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 101150006213 ackA gene Proteins 0.000 description 4
- JGGLZQUGOKVDGS-VYTIMWRQSA-N aspartate semialdehyde Chemical compound O[C@@H]1[C@@H](NC(=O)C)CO[C@H](CO)[C@H]1O[C@@H]1[C@@H](NC(C)=O)[C@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@H](CO)O3)O)[C@@H](O)[C@H](CO[C@@H]3[C@H]([C@H](O[C@@H]4[C@H]([C@H](O)[C@@H](O)[C@H](CO)O4)O)[C@@H](O)[C@H](CO)O3)O)O2)O)[C@H](CO)O1 JGGLZQUGOKVDGS-VYTIMWRQSA-N 0.000 description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 4
- 229960002079 calcium pantothenate Drugs 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 4
- 235000019157 thiamine Nutrition 0.000 description 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- 239000011721 thiamine Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- -1 NCgl2083) Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 238000010923 batch production Methods 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 230000034659 glycolysis Effects 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102000011045 Chloride Channels Human genes 0.000 description 2
- 108010062745 Chloride Channels Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010001267 Protein Subunits Proteins 0.000 description 2
- 102000002067 Protein Subunits Human genes 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 101150100998 Ace gene Proteins 0.000 description 1
- 102000008146 Acetate-CoA ligase Human genes 0.000 description 1
- 108010049926 Acetate-CoA ligase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 1
- 241000337023 Corynebacterium thermoaminogenes Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102220466851 HLA class II histocompatibility antigen, DR beta 4 chain_V59A_mutation Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000500375 Microbacterium sp. Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 101710197985 Probable protein Rev Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 108030003822 Succinyl-CoA:acetate CoA-transferases Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000037341 glyoxalate cycle Effects 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 108010071598 homoserine kinase Proteins 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 101150035025 lysC gene Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y403/00—Carbon-nitrogen lyases (4.3)
- C12Y403/03—Amine-lyases (4.3.3)
- C12Y403/03007—4-Hydroxy-tetrahydrodipicolinate synthase (4.3.3.7)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Description
DESCRIPTION
BACKGROUND 1. Field [0001] One or more embodiments of the present invention relate to a method of producing L-amino acids by using a gene transcription inhibition method. 2. Description of the Related Art [0002] Pyruvate, which is produced through glycolysis of various carbon sources in coryneform microorganisms, is converted into aspartate via oxaloacetate. The aspartate is converted into amino acids such as threonine, methionine, isoleucine, and lysine through various biosynthetic pathways (FIG. 1). Therefore, the expression of genes, located at each branch point in the amino acid biosynthetic processes, may be inhibited to decrease byproduct production and increase target amino acid production.
[0003] As described above, to develop a microorganism strain, which is capable of high-potency production of target materials by using genetic engineering and metabolic engineering, the expression of genes related with various metabolic processes of a microorganism needs to be selectively controlled. Recently, a technology for weakening gene expression, which is called "artificial convergent transcription," was reported (Krylov et al., J Mol Microbiol Biotechnol, 18:1-13, 2010). The artificial convergent transcription is a technology for weakening the expression of a target gene by inserting a promoter into a downstream region of a transcription terminator of the target gene so that the opposite direction of the promoter causes a collision of RNA polymerase complexes derived from each promoter during transcription.
[0004] The inventors developed a technology to selectively inhibit the expression of a target gene in the presence of acetate by inserting an acetate-inducible promoter in a direction opposite to the target gene transcription, and effectively applied the technology to inhibit the expression of genes located at branch points in a coryneform microorganism. Then the inventors verified to provide the coryneform microorganism of producing L-amino acid with high yield by using the technology and completed the present invention.
SUMMARY
[0005] The purpose of the present invention is to provide a method of producing L-amino acids by using an acetate-inducible promoter to inhibit transcription of a target gene.
[0006] Accordingly the present invention provides a method of producing L-amino acids, the method comprising 1. 1) culturing a recombinant coryneform microorganism capable of producing L-amino acids, wherein the recombinant coryneform microorganism has an acetate-inducible promoter downstream of a stop codon of a target gene in a chromosome; and 2. 2) adding acetate during the culturing to weaken expression of the target gene, and to strengthen the L-amino acids production capability of the recombinant coryneform microorganism, wherein the acetate-inducible promoter is in a direction opposite to the target gene transcription.
The preferred features are defined in claims 2 to 5.
BRIEF DESCRIPTION OF THE DRAWINGS
[0007] These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which: FIG. 1 shows branch points of the amino acids biosynthesis process in a coryneform microorganism; and FIG. 2 is a schematic diagram showing inhibition of aceE gene expression by inserting an aceA gene promoter a) between the stop codon and the transcription terminator upstream of the aceE gene or b) downstream of the transcription terminator in a direction opposite to the direction of the aceE gene transcription.
DETAILED DESCRIPTION
[000S] Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. Expressions such as "at least one of," when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.
[0009] Hereinafter, the present invention is described in detail.
[0010] The present invention provides a method of producing L-amino acids, the method comprising: 1. 1) culturing a recombinant coryneform microorganism capable of producing L-amino acids, wherein the recombinant coryneform microorganism has an acetate-inducible promoter downstream of a stop codon of a target gene in a chromosome; and 2. 2) adding acetate during the culturing to weaken the expression of the target gene, and to strengthen the L-amino acids production capability of the recombinant coryneform microorganism, wherein the acetate-inducible promoter is in a direction opposite to the target gene transcription.
[0011] The term "acetate-inducible promoter" used herein refers to a promoter having gene expression-inducing activity in the presence of acetate.
[0012] In a coryneform microorganism, acetate is converted by acetate kinase (ackA, NCgl2656) and phosphotransacetylase (pta, NCgl2657), or by succinyl-CoA:acetate CoA-transferase (actA, NCgl2480), into acetyl CoA, and then metabolized by isocitrate lyase (aceA, NCgl2248) in a glyoxalate cycle. In Escherichia coii, acetate is converted into acetyl CoA by acetyl-CoA synthetase (aes, b4069) (Gerstmeir et al., J Biotechnol, 104:99-122, 2003). The expression of the mentioned genes involved in the acetate metabolism is induced in the presence of acetate. Therefore, when the promoters of the genes are used, the expression of the gene may be specifically induced in the presence of acetate.
[0013] Acetate-inducible promoters include a promoter of a gene encoding isocitrate lyase (aceA, NCgl2248) or a promoter of an operon of a gene encoding acetate kinase (ackA, NCgl2656) and a gene encoding phosphotransacetylase (pta, NCgl2657), which is an upstream promoter of the pta gene. More specifically, among the acetate-inducible promoters described above, the promoter of the aceA gene is represented by nucleotide sequence of SEQ ID NO: 1 and includes 486 base pairs upstream of the aceA gene and 36 base pairs from an N-terminal of an open reading frame (ORF).
[0014] Upstream promoter of the pta gene, which is another acetate-inducible promoter, is represented by nucleotide sequence of SEQ ID NO: 2 and includes 340 base pairs upstream of the pta gene.
[0015] In addition, it is obvious that any promoter capable of inducing a target gene expression by acetate may be included in the scope of the present invention. For example, the acetate-inducible promoters may include a nucleotide sequence including the nucleotide sequence of SEQ ID NO: 1 or 2, or including a conserved sequence of the nucleotide sequence of SEQ ID NO: 1 or 2, and one or a plurality of nucleotides (specifically 2 to 20 , more specifically, 2 to 10, further more specifically, 2 to 5 nucleotides, depending on the steric conformation of amino acid residues of a protein) that are substituted, deleted, inserted, added, or inversed at one or more locations. As long as the function of the inducible promoter is maintained or strengthened, it may include a nucleotide sequence has more than 80% homology with the nucleotide sequence of SEQ ID NO: 1 or 2, , specifically by more than 90%, more sepecifically by more than 95%, further more specifically by more than 97%. As long as the function of the inducible promoter is maintained, the substituted, deleted, inserted, added, or inversed nucleotide sequence may include a spontaneous mutant sequence or even an artificial mutant sequence.
[0016] The term "homology" used herein refers to the identity between two different nucleotide sequences. Homology may be determined by a method known in this art by using a BLAST 2.0 software program which calculates such parameters as score, identity, and similarity. However, the method of determining homology is not limited thereto.
[0017] Unless mentioned otherwise herein, the term "upstream" refers to a 5' direction, and the term "downstream" refers to a 3' direction. Usually, the direction of the transcription proceeding is 5' to 3', so that the promoter position is usually the upstream(5') of the target gene.
[0018] Herein, a target gene in a chromosome may be a gene involved in a process of biologically synthesizing amino acids such as threonine, methionine, isoleucine, and lysine from various carbon sources, especially a gene located at a branch point of a biosynthetic pathway.
[0019] For example, with respect to lysine, a pyruvate dehydrogenase subunit E1 (aceE, NCgl2167) gene which is involved in the conversion of pyruvate into acetyl CoA, a homoserine dehydrogenase (horn, NCgl1136) gene which produces homoserine from aspartate, and a UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase (murE, NCgl2083) gene which uses meso-2,6-diaminopimelate that is a precursor of lysine in somatic synthesis, are located at branch points of the biosynthetic pathway.
[0020] In addition, a dihydrodipicolinate synthase (dapA, NCgl1896) gene involved in producing lysine from aspartate is at a branch point with respect to threonine, and a homoserine kinase (thrB, NCgl1137) gene involved in producing threonine from homoserine is at a branch point with respect to methionine. With respect to alanine and valine that are pyruvate-derived amino acids, a pyruvate dehydrogenase subunit E1 (aceE, NCgl2167) gene involved in the conversion of pyruvate into acetyl CoA is at a branch point.
[0021] Therefore, a target gene may be selected from the group consisting of a gene encoding a pyruvate dehydrogenase subunit E1 (aceE, NCgl2167), a gene encoding homoserine dehydrogenase (horn, NCgl1136), a gene encoding a UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase (murE, NCgl2083), and a gene encoding dihydrodipicolinate synthase (dapA, NCgl1896), but is not limited thereto.
[0022] Specifically, the pyruvate dehydrogenase subunit E1 (aceE, NCgl2167) is one of the protein subunits of pyruvate dehydrogenase complex (PDHC), which is involved in the inflow of pyruvate that is a final metabolite of glycolysis to a tricarboxylic acid cycle (TCA cycle). Therefore, weakening the expression of the aceE gene may decrease the inflow of carbon sources to a TCA cycle and increase the inflow of carbon sources to a lysine biosynthetic pathway to increase lysine production.
[0023] Homoserine dehydrogenase (horn, NCgH 136) is an enzyme synthesizing homoserine from aspartate semialdehyde. Since aspartate semialdehyde is one of the intermediate precursors of a lysine biosynthetic pathway, weakening the horn gene activity may decrease the inflow of carbon sources to a homoserine biosynthetic pathway and increase the inflow of carbon sources to a lysine biosynthetic pathway to increase lysine production.
[0024] UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase (murE, NCgl2083) uses meso-2,6-diaminopimelate for somatic synthesis. Since meso-2,6-diaminopimelate is also used as a precursor for lysine biosynthesis, weakening of the murE gene activity may decrease the inflow of carbon sources to somatic synthesis and increase the inflow of carbon sources to a lysine biosynthetic pathway to increase lysine production.
[0025] Dihydrodipicolinate synthase (dapA, NCgl1896) is an enzyme which is involved in lysine production by using aspartate semialdehyde. Since aspartate semialdehyde is one of the intermediate precursors of a lysine biosynthetic pathway, weakening of the dapA gene activity may decrease the inflow of carbon sources to lysine biosyntheric pathway and increase the inflow of carbon sources to a threonine biosynthetic pathway to increase threonine production.
[0026] The term "stop codon" used herein refers to codons that do not encode an amino acid on mRNA, but operate as a signal for termination of protein synthesis. Three codons including UAA, UAG, and UGAare used conventionally as stop codons.
[0027] The term "transcription terminator" used herein refers to a GC base-rich inverted repeat sequence. A transcription terminator forms a hairpin loop to terminate gene transcription.
[0028] In the present invention, to weaken the expression of a target gene, as described above, an acetate-inducible promoter may be introduced downstream of a stop codon of a target gene, specifically, between a stop codon and upstream of a transcription terminator. An acetate-inducible promoter may be used to cause an inverse transcription of a target gene so that RNA polymerase complexes may conflict with each other to weaken the expression of a target gene.
[0029] The expression of a target gene may be weakened any time of culturing. More specifically the expression of a target gene may be weakened before or during culturing.
[0030] The term "transformation" used herein refers to introducing a vector including a polynucleotide which encodes a target gene into a host cell so that a protein encoded by the polynucleotide may be expressed in the host cell. As long as an introduced polynucleotide may be expressed in a host cell, the polynucleotide may be inserted into the chromosome of the host cell or exist out of the chromosome. In addition, the polynucleotide includes DNA or RNA encoding a target protein. As long as the polynucleotide can be introduced into and expressed in a host cell, the polynucleotide may be introduced in any form.
[0031] In an embodiment of the invention, the coryneform microorganism may include microorganisms of genus Corynebacterium, genus Brevibacterium, genus Arthrobacter sp., and genus Microbacterium sp.. Examples of the coryneform microorganism include Corynebacterium glutamicum, Corynebacterium thermoaminogenes, Brevibacterium flavum, Brevibacterium lactofermentum, and L-amino acid-producing variants prepared therefrom. Specifically, the coryneform microorganism may be Corynebacterium glutamicum, but is not limited to these examples.
[0032] More specifically, the coryneform microorganisms in the present invention may include Corynebacterium glutamicum KCCM11016P (Former Accession NO: KFCC10881, Refer to Korean Patent NO: 10-0159812), Corynebacterium glutamicum KCCM10770P (Refer to Korean Patent NO: 10-0924065), and Corynebacterium glutamicum KCCM11347P (Former Accession NO: KFCC10750, Refer to Korean Patent NO: 10-0073610).
[0033] Corynebacterium glutamicum CJ3P may be also included the coryneform microorganisms in the present invention. CJ3P has been developed to have lysine-producing capability by introducing mutation to three genes involved in lysine-producing efficiency (pyc(P458S), hom(V59A), and lysC(T3111)) to a parent strain, a wild type Corynebacterium glutamicum (ATCC13032) according to the report by Binder et al. (Binder et al., Genome Biology, 13:R40, 2012).
[0034] In addition, another coryneform microorganism in the present invention may be Corynebacterium glutamicum KCCM11222P, which is an L-threonine-producing strain (Refer to Korean Patent NO: 10-1335853).
[0035] According to one embodiment of the present invention, in all the coryneform microorganisms to which a promoter being represented by nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 2 was introduced, the L-lysine or L-threonine productivity was increased compared to that of the parent strain.
[0036] With respect to the method provided in the present invention, culturing of a coryneform microorganism may be performed by applying any culturing conditions and culturing method known in this art.
[0037] A culture medium, which may be used in culturing of a coryneform strain, may be, for example, the culture mediums described in Manual of Methods for General Bacteriology by the American Society for Bacteriology (Washington D.C., USA, 1981).
[0038] The carbon sources, which may be used in the culture medium, may include a carbohydrate such as glucose, saccharose, lactose, fructose, maltose, starch, and cellulose, an oil or lipid such as soybean oil, sunflower oil, castor oil, and coconut oil, a fatty acid such as palmitic acid, stearic acid, and linoleic acid, an alcohol such as glycerol and ethanol, and an organic acid such as acetic acid. These substances may be individually or as a mixture.
[0039] The nitrogen sources, which may be used in the culture medium, may include peptone, yeast extract, beef extract, malt extract, corn steep liquid, soybean, and urea, and an inorganic nitrogen source such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate, and ammonium nitrate. These nitrogen sources also may be individually or as a mixture.
[0040] The phosphorous sources, which may be used in the culture medium, may include potassium dihydrogen phosphate, dipotassium hydrogen phosphate, and a sodium-containing salt thereof. In addition, a culture medium may have to include a metal salt such as magnesium sulfate and iron sulfate needed for growth. Beside the substances described above, necessary substances for growth such as amino acids and vitamins may be used. In addition, appropriate precursors may be used in a culture medium. The raw materials may be added to the culture solution in a batch mode or a continuous mode during the culturing.
[0041] During the culturing of the microorganism, the pH of the culture medium may be adjusted by adding a basic compound such as ammonium hydroxide, potassium hydroxide, and ammonia, or an acidic compound such as phosphoric acid and sulfuric acid to the culture medium in an appropriate mode. In addition, bubble formation may be repressed by using an anti-forming agent such as fatty acid polyglycol ester. To maintain aerobic conditions, oxygen or an oxygen-containing gas (for example, air) may be injected to the culture medium. The temperature of the culture medium may be usually from about 20 °C to about 45 °C, specifically, from about 25 °C to about 40 °C. The culturing may continue until a desired amount of an L-amino acid is produced, but an appropriate culturing time may be from about 10 to 160 hours.
[0042] With respect to the method provided in the present invention, culturing may be performed in a continuous mode or a batch mode such as a batch process, a fed-batch process, and a repeated fed-batch process. These culturing methods are known in the art, and any of the culturing methods may be used.
[0043] The term "culturing" used herein may include both preparing a culture medium and the time during growing the microorganisms.
[0044] With respect to the method provided in the present invention, the method may include further purifying or recovering step. A target L-amino acid may be purified or recovered from a culture solution by using an appropriate method known in this art according to the method such as batch culturing, continuous culturing, and fed-batch culturing.
[0045] An L-amino acid produced in the culturing of the present invention may be one selected from the group consisting of threonine, methionine, isoleucine, lysine, valine, and alanine, specifically, lysine or threonine.
[0046] Hereinafter, the present invention will be described in further detail with reference to examples. These examples are illustrative purposes only and the scope of the present invention is not limited thereto.
Examples
Example 1: Selection of Acetate-Inducible Promoter [0047] Isocitrate lyase (aceA, NCgl2248) is a key enzyme of a glyoxylate cycle, and a gene encoding isocitrate lyase is expressed in the presence of acetate. In addition, acetate kinase (ackA, NCgl2656) and phosphotransacetylase (pta, NCgl2657), which are enzymes that are involved in an acetate metabolic process, form an operon, and the expression thereof is strengthened in the presence of acetate. The promoter regions of the aceA gene and the pta-ackA operon are already known (Gerstmeir et al., J Biotechnol, 104, 99-122,2003).
[0048] In Example 1, a promoter of the aceA gene and a promoter of the pta-ack operon that is an upstream promoter region of the pta gene were selected to inhibit the transcription of a target gene in the presence of acetate. Based on the aceA gene registered in the US NIH GenBank (NCBI Registration NO: NCgl2248), a nucleotide sequence (SEQ ID NO: 1), including 486 base pairs upstream of the aceA gene and 36 base pairs from an N-terminal of an open reading frame (ORF), was obtained. In addition, Based on the pta gene registered in the US NIH GenBank (NCBI Registration NO: NCgl2657), a nucleotide sequence (SEQ ID NO: 2), including 340 base pairs upstream of the pta gene, was obtained.
Example 2: Preparation of Vector for Inhibiting aceE Gene Expression [0049] A pyruvate dehydrogenase subunit E1 (aceE, NCgl2167) is one of the protein subunits of pyruvate dehydrogenase complex (PDHC), which is involved in inflowing pyruvate that is a final metabolite of glycolysis to a TCA cycle. Therefore, weakening the expression of the aceE gene may decrease the inflow of carbon sources to a TCA cycle and increase the inflow of carbon sources to a lysine biosynthetic pathway to increase lysine production (Blombach et al., Appl Microbiol Biotechnol, 76(3):615-23, 2007).
[0050] The aceA gene promoter was inserted downstream of the aceE gene so that the transcription from this promoter may occur in a direction opposite to the original direction of the aceE gene transcription to inhibit the expression of the aceE gene selectively in the presence of acetate (FIG. 2).
[0051] Firstly, CLC main workbench software (CLC Bio, Denmark) was used to predict a transcription terminator of the aceE gene. A transcription terminator is a GC base-rich inverted repeat sequence and forms a hairpin loop to terminate gene transcription. The result of predicting a transcription terminator of the aceE gene showed that 36 base pairs, from the 21 st base pair to the 56th base pair downstream from the stop codon of the aceE gene, form a hairpin loop as a transcription terminator. Based on this result, two vectors were prepared to insert aceE promoter into either upstream or downstream, respectively, of the transcription terminator of aceE gene so that the transcription from the this promoter may occur in a opposite direction of the original one. <2-1> Preparation of pDZ-aceE1-PaceA Vector for Inhibiting aceE Gene Expression [0052] A vector was prepared by inserting an aceAgene promoter downstream of the aceE gene stop codon, which is between the stop codon and upstream of the transcription terminator.
[0053] To obtain a fragment of a Corynebacterium glutamicum-derived aceE gene, the chromosomal DNA of Corynebacterium glutamicum KCCM11016P was used as a template to synthesize primers (SEQ ID NOs: 3 and 4), which were designed to have an Xbal restriction enzyme recognition site at a 5' end of the fragment and an Spel restriction enzyme recognition site at a 3' end of the fragment. A PCR was performed by using the synthesized primers to obtain a DNA fragment including 296 base pairs between the 2474th nucleotide from the start codon of aceE gene and the 2769th nucleotide, a stop codon of aceE gene. In addition, primers (SEQ ID NOs: 5 and 6), which were designed to have an Spel recognition site at a 5' end of the fragment and an Xbal recognition site at a 3' end of the fragment were synthesized, and a PCR was performed by using the primers to obtain a DNA fragment including 300 base pairs downstream of the aceE gene stop codon. PfuUltra™ High-Fidelity DNA Polymerase (Stratagene) was used as a polymerase, and a PCR was performed with 30 cycles of denaturing at 95°C for 30 seconds; annealing at 55°C for 30 seconds; and polymerization at 72°C for 30 seconds and then polymerization at 72°C for 7 minutes.
[0054] The two PCR amplification products and a pDZ vector (Refer to Korean Patent NO: 10-0924065) for chromosomal introduction that had already been prepared by cleaving with an Xbal restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-aceE1 vector. SEQ ID NO: 3: aceE-P1 F 5'- ccggggatcctctagacctccggcccatacgttgc-3' SEQ ID NO: 4: aceE-P1 R 5'- ttgagactagttattcctcaggagcgtttg -3' SEQ ID NO: 5: aceE-P2F 5'- gaataactagtctcaagggacagataaatc -3' SEQ ID NO: 6: aceE-P2R 5'- gcaggtcgactctagagaccgaaaagatcgtggcag -3' [0055] To obtain a promoter fragment of a Corynebacterium glutamicum-derived aceA gene, primers which were designed to have an Spel restriction enzyme recognition site at a 5' end and at a 3' end of the fragment (SEQ ID NOs: 7 and 8) were synthesized. The PCR was performed using the chromosomal DNA of Corynebacterium glutamicum KCCM11016P as a template and the synthesized primers to amplify a promoter region of about 500 base pairs being represented by a nucleotide sequence of SEQ ID NO: 1. The PCR amplification product and a DNA fragment that was obtained by treating a pDZ-aceE1 with Spel restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-aceE1-PaceA vector. SEQ ID NO: 7: PaceA-P3F 5'- gtcccttgagactagtagcactctgactacctctg -3' SEQ ID NO: 8: PaceA-P3R 5'- ctgaggaata actagtttcctgtgcggtacgtggc -3' <2-2> Preparation of pDZ-aceE2-PaceA Vector for Inhibiting ace Gene Expression [0056] A vector was prepared by inserting an aceA gene promoter downstream of the aceE gene transcription terminator.
[0057] To obtain a fragment of a Corynebacterium glutamicum-derived aceE gene, the chromosomal DNA of Corynebacterium glutamicum KCCM11016P was used as a template, and primers, which were designed to have an Xbal restriction enzyme recognition site at a 5' end of the fragment and an Spel restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 9 and 10), were used. APCR was performed by using the synthesized primers to obtain a DNAfragment including 294 base pairs between the 2538th nucleotide from the start codon of aceE gene and the 62nd nucleotide downstream of the stop codon. In addition, primers, which were designed to have an Spel restriction enzyme recognition site at a 5' end of the fragment and an Xbal restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 11 and 12), were used to perform a PCR to obtain a DNA fragment including 294 base pairs between the 69th nucleotide downstream of the aceE gene stop codon and the 362nd nucleotide. PfuUltra™ High-Fidelity DNA Polymerase (Stratagene) was used as a polymerase, and a PCR was performed with 30 cycles of denaturing at 95°C for 30 seconds; annealing at 55°C for 30 seconds; and polymerization at 72°C for 30 seconds and then polymerization at 72°C for 7 minutes.
[0058] The two PCR amplification products and a pDZ vector for chromosomal introduction that had already been prepared by cleaving with an Xbal restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-aceE2 vector. SEQ ID NO: 9: aceE-P4F 5'- ccggggatcctctagaggtcccaggcgactacacc-3' SEQ ID NO: 10: aceE-P4R 5'- gagctactagtacgacgaatcccgccgccagacta -3' SEQ ID NO: 11: aceE-P5F 5'- gtcgtactagtagctctttttagccgaggaacgcc-3' SEQ ID NO: 12: aceE-P5R 5'- gcaggtcgactctagacatgctgttggatgagcac -3' [0059] To obtain a promoter fragment of a Corynebacterium glutamicum-derived aceA gene, primers, which were designed to have an Spel restriction enzyme recognition site at a 5' end and at a 3' end of the fragment (SEQ ID NOs: 13 and 14), were synthesized. The PCR was performed using the chromosomal DNA of Corynebacterium glutamicum KCCM11016P as a template and the synthesized primers to amplify a promoter region of about 500 base pairs being represented by a nucleotide sequence of SEQ ID NO: 1. The PCR amplification product and a DNA fragment that was obtained by treating a pDZ-aceE2 vector with Spel restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-aceE2-PaceA vector. SEQ ID NO: 13: PaceA-P6F 5'- aaaaagagctactagtagcactctgactacctctg -3' SEQ ID NO: 14: PaceA-P6R 5'- gattcgtcgtactagtttcctgtgcggtacgtggc-3'
Example 3: Preparation of Strains in Which aceA Gene Promoter is Inserted Downstream of aceE Gene [0060] The pDZ-aceE1-PaceA and pDZ-aceE2-PaceA vectors prepared in Example 2 were introduced respectively by electric pulsing into Corynebacterium glutamicum KCCM11016P that is an L-lysine-producing strain (transformation method described in Van der Rest et al., Appl Microbiol Biotechnol, 52:541-545, 1999). The respective strains in which an aceA gene promoter was inserted downstream of the aceE gene stop codon on the chromosome so that the transcription from this promoter may occur in a direction opposite to the original direction were selected by performing a PCR to obtain an L-lysine-producing strain. The selected strains were named as Corynebacterium glutamicum KCCM11016P::aceE1-PaceA, and as Corynebacterium glutamicum KCCM11016P::aceE2-PaceA, respectively. Corynebacterium glutamicum KCCM11016P::aceE1-PaceA was internationally deposited in the name of Corynebacterium glutamicum CA01-2271 to Korean Culture Center of Microorganism (KCCM) on June 12, 2013 with Accession Number KCCM11432P. The prepared strains were verified that the nucleotide sequence of target region obtained was analyzed by performing a PCR using SEQ ID NO: 3 and SEQ ID NO: 6 as primers for KCCM11016P::aceE1-PaceA, and SEQ ID NO: 9 and SEQ ID NO: 12 for as primers for KCCM11016P::aceE2-PaceA.
Example 4: Comparison of Lvsine Productivity of Strains in Which aceA Gene Promoter is Inserted Downstream of aceE Gene [0061] Corynebacterium glutamicum KCCM11016P strain which was used as a parent strain, and Corynebacterium glutamicum KCCM11016P::aceE1-PaceA and Corynebacterium glutamicum KCCM11016P::aceE2-PaceA which were the L-lysine-producing strains prepared in Example 3 were cultured by the method described below.
[0062] Corynebacterium glutamicum KCCM11016P KCCM11016P::aceE1-PaceA, and KCCM11016P::aceE2-PaceA were inoculated respectively to 25 ml of the seed medium described below in 250 ml corner-baffled flasks, followed by shaking culture at 200rpm at 30 °C for 20 hours. 1 ml of the seed culture solution was added to a 250 ml corner-baffled flask including 24 ml of the production medium described below, followed by shaking culture at 200rpm at 30 °C for 72 hours. The respective compositions of the seed medium and the production mediums are described below. <Seed medium (pH 7.0)> [0063] glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, a KH2PO4 4 g, K2HPO4 8 g, MgSC>4*7(H20) 0.5 g, biotin 100 pg, thiamine HCI 1000 pg, calcium pantothenate 2000 pg, nicotinamide 2000 pg (with reference to 1 L of distilled water).
Production medium (pH 7.0)> [0064] glucose 100 g, (NH4)2S04 40 g, soy protein 2.5 g, corn steep solids 5 g, urea 3 g, KH2PO4 1 g, MgSC>4*7(H2C>) 0.5 g, biotin 100 pg, thiamine HCI 1000 pg, calcium pantothenate 2000 pg, nicotinamide 3000 pg, CaCC>3 30 g (with reference to 1 Lof distilled water), [0065] After the culturing, the L-lysine concentration was measured using HPLC. When acetate was not added, the L-lysine concentration in the culture solutions of Corynebacterium glutamicum KCCM11016P, KCCM11016P::aceE1-PaceA, and KCCM11016P::aceE2-PaceA is shown in Table 1.
Table 1. Variation of L-lysine production (acetate not added)
[0066] In addition, the strains were cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-lysine production. The L-lysine concentration in the culture solutions is shown in Table 2.
Table 2. Variation of L-lysine production (5 g/L of acetate added)
[0067] As shown in Table 1, in the absence of acetate, the L-lysine productivity of KCCM11016P::aceE1-PaceA and KCCM11016P::aceE2-PaceA strains was not different from that of the parent strain KCCM11016P.
[0068] However, as shown in Table 2, in the presence of acetate, the L-lysine productivity of the KCCM11016P::aceE1-PaceA strain was over 3.6% higher than that of the parent strain KCCM11016P, and that of the KCCM11016P::aceE2-PaceA strain was over 2.5% higher than that of the parent strain KCCM11016P.
[0069] In addition, comparison of the KCCM11016P::aceE1-PaceA strain and the KCCM11016P::aceE2-PaceA strain shows that the L-lysine production of the KCCM11016P::aceE1-PaceA strain in which the aceA promoter was inserted upstream of the aceE gene transcription terminator, which was between the stop codon and upstream of the transcription terminator, was more effective. It indicates that the region between the stop codon and upstream of the transcription terminator may be used to inhibit gene expression more effectively.
Example 5 : Preparation of pDZ-aceE-Ppta Vector for Inhibiting aceE Gene Expression [0070] Acetate kinase (ackA, NCgl2656) and phosphotransacetylase (pta, NCgl2657), which are enzymes that are involved in an acetate metabolic process, form an operon, and the expression thereof is strengthened in the presence of acetate. Therefore, when the promoters of the genes are used, the expression of a gene may be specifically induced in the presence of acetate.
[0071] In Example 5, to inhibit the expression of the aceE gene in the presence of acetate, a vector for using a pta-ack operon promoter that was the pta gene upstream promoter region was prepared.
[0072] To inhibit the expression of the aceE gene, a vector which may comprise a pta gene promoter downstream of the aceE gene stop codon, which is between the stop codon and upstream of the transcription terminator, was constructed so that the transcription from pta gene promoter may occur in a direction opposite to the original direction of the aceE gene transcription.
[0073] To obtain a fragment of a Corynebacterium glutamicum-derived aceE gene, the chromosomal DNA of Corynebacterium glutamicum KCCM11016P was used as a template to prepare a pDZ-aceE1 vector by the same method as Example 2.
[0074] To obtain a promoter fragment of a Corynebacterium glutamicum-derived pta gene, primers, which were designed to have an Spel restriction enzyme recognition site at a 5' end and at a 3' end of the fragment (SEQ ID NO: 15 and SEQ ID NO: 16), were synthesized. The chromosomal DNA of Corynebacterium glutamicum KCCM11016P as a template, and the synthesized primers were used to perform a PCR to amplify a promoter region of about 340 base pairs being represented by a nucleotide sequence of SEQ ID NO: 2. The PCR amplification product and a DNA fragment that was obtained by treating a pDZ-aceE1 vector with a Spel restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-aceE1-Ppta vector. SEQ ID NO: 15: Ppta-P7F 5'-gtcccttgagactagtctttgctggggtcagatttg-3' SEQ ID NO: 16: Ppta-P7R 5'- ctgaggaataactagtacatcgcctttctaatttc-3'
Example 6: Preparation of Strains in Which Pta Gene Promoter is Inserted Downstream of aceE Gene and Comparison of Lvsine Productivity thereof [0075] The Corynebacterium glutamicum KCCM11016P was transformed with the pDZ-aceE1-Ppta vector prepared in Example 5 by the same method as Example 3. The strain in which a pta gene promoter was inserted downstream of the aceE gene stop codon on the chromosome so that the transcription may occur in a direction opposite to the original direction of the aceE gene transcription was selected by performing a PCR to obtain an L-lysine-producing strain, which was named as KCCM11016P::aceE1-Ppta. The prepared KCCM11016P::aceE1-Ppta strain was verified that the nucleotide sequence of target region obtained was analyzed by performing a PCR using SEQ ID NO: 3 and SEQ ID NO: 6 as primers.
[0076] The prepared strain was cultured by the same method as Example 4, and the concentration of L-lysine recovered from the culture solution was measured. When acetate was not added, the L-lysine concentration in the culture solution is shown in Table 3.
Table 3. Variation of L-lysine production (acetate not added)
[0077] In addition, the strain was cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-lysine production. The L-lysine concentration in the culture solution is shown in Table 4.
Table 4. Variation of L-lysine production (5 g/L of acetate added)
[0078] As shown in Table 3, in the absence of acetate, the L-lysine productivity of the KCCM11016P::aceE1-Ppta strain was not different from that of the parent strain KCCM11016P.
[0079] However, as shown in Table 4, in the presence of acetate, the L-lysine productivity of the KCCM11016P::aceE1-Ppta strain was over 2.4% higher than that of the parent strain KCCM11016P.
[0080] In addition, since the L-lysine productivity of the KCCM11016P::aceE1-PaceA strain was higher than that of the KCCM11016P::aceE1-Ppta strain, in the presence of acetate, the expression of a target gene may be inhibited more effectively by using the aceA gene promoter than by using the pta gene promoter.
Example 7: Preparation of Strains in Which aceA Gene Promoter is Inserted Downstream of aceE Gene [0081] Three L-lysine-producing strains which were Corynebacterium glutamicum KFCC10750, KCCM10770P, and CJ3P were transformed respectively with the pDZ-aceE1 -PaceA vector prepared in Example 2 by the same method as Example 3. The strains in which an aceA gene promoter was inserted downstream of the aceE gene stop codon on the chromosome so that the transcription may occur in a direction opposite to the original direction of the aceE gene transcription was selected by performing a PCR. The obtained three L-lysine-producing strains were KFCC10750::aceE1-PaceA, KCCM10770P::aceE1-PaceA, and CJ3P::aceE1-PaceA. The prepared strains were verified that the nucleotide sequence of target region obtained was analyzed by performing a PCR using SEQ ID NO: 3 and SEQ ID NO: 6 as primers.
[0082] The prepared strains were cultured by the same method as Example 4, and the concentration of L-lysine recovered from the culture solutions was measured. When acetate was not added, the L-lysine concentration in the culture solutions is shown in Table 5.
Table 5. Variation of L-lysine production (acetate not added)
[0083] In addition, the strains were cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-lysine production. The L-lysine concentration in the culture solutions is shown in Table 6.
Table 6. Variation of L-lysine production (5 g/L of acetate added)
[0084] As shown in Table 5, in the absence of acetate, the L-lysine productivity of the three KFCC10750::aceE1-PaceA, KCCM10770P::aceE1-PaceA, CJ3P::aceE1-PaceA strains was not different from that of the parent strain.
[0085] However, as shown in Table 6, in the presence of acetate, the L-lysine productivity of the KFCC10750::aceE1-PaceA strain was 5% higher than that of the parent strain, that of the KCCM10770P::aceE1-PaceAstrain was 2.8% higher than that of the parent strain, and that of the CJ3P::aceE1-PaceA strain was 15% higher than that of the parent strain.
Example 8 : Preparation of Vector for Inhibiting hom Gene Expression [0086] L -threonine biosynthetic pathway using a same substrate as L-lysine biosynthetic pathway may be weakened to increase L-lysine productivity. An example of the methods of weakening L-threonine biosynthetic pathway is to decrease the enzymatic activity of homoserine dehydrogenase (hom, NCgH 136) which produces homoserine from aspartate.
[0087] In Corynebacterium glutamicum, the hom gene forms hom-thrB operon with thrB gene, and the transcription terminator of the hom gene exists downstream of the thrB gene. It was reported that a promoter exists upstream of the hom-thrB operon that is upstream of the hom gene. In addition, it was reported a second promoter exists upstream of the thrB gene operon (Mateos et al., J Bacteriol, 176:7362-7371, 1994). Therefore, an aceA gene promoter was inserted downstream of the hom gene stop codon so that the trascription from this promoter may occur in a direction opposite to the original direction of the hom gene transcription in order to selectively inhibit the expression of the hom gene in the presence of acetate. To maintain the expression of the thrB gene, a second promoter sequence was added upstream of thrB gene ORF.
[0088] In Example 8, a recombinant vector was prepared by inserting an aceA gene promoter between downstream of the hom gene stop codon and upstream of the thrB gene.
[0089] To obtain a fragment of a Corynebacterium glutamicum-derived hom gene, the chromosomal DNAof Corynebacterium glutamicum KCCM11016P was used as a template, and primers, which were designed to have an Xbal restriction enzyme recognition site at a 5' end of the fragment and an Spel restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 17 and 18), were synthesized. A PCR was performed using the synthesized primers to obtain a DNAfragment including 300 base pairs between the 1039th nucleotide from the hom gene start codon and the 1338th nucleotide which was a stop codon. Even when an aceA is inserted between the hom-thrB operons, the expression of the thrB gene should be maintained. Therefore, when the DNA fragment including the 300 base pairs of the hom gene stop codon downstream was prepared, primers which were designed to further add a thrB promoter sequence of 32 base pairs to a 5' side (SEQ ID NOs: 19 and 20) were synthesized. A PCR was performed using these primers (SEQ ID NOs: 19 and 20) to obtain a DNA fragment of 334 base pairs having an Spel restriction enzyme recognition site at a 5' end of the fragment and an Xbal restriction enzyme recognition site at a 3' end of the fragment. The PCR was performed under the same conditions as Example 2.
[0090] The two PCR amplification products and a pDZ vector for chromosomal introduction that had already been prepared by cleaving with an Xbal restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-hom vector. SEQ ID NO: 17: hom-h1F 5'- ccggggatcctctagaccaggtgagtccacctacg -3' SEQ ID NO: 18: hom-h1R 5'- gaggcggatcactagtttagtccctttcgaggcgg -3' SEQ ID NO: 19: hom-h2F 5'- actagtgatccgcctcgaaagggac-3' SEQ ID NO: 20: hom-h2R 5'- gcaggtcgactctagagactgcggaatgttgttgtg -3' [0091] To obtain a promoter fragment of a Corynebacterium glutamicum-derived aceA gene, primers which were designed to have an Spel restriction enzyme recognition site at a 5' end and at a 3' end of the fragment (SEQ ID NOs: 21 and 22) were synthesized. The PCR was performed using the chromosomal DNAof Corynebacterium glutamicum KCCM11016P as a template, and the synthesized primers to amplify a promoter region of about 500 base pairs being represented by a nucleotide sequence of SEQ ID NO: 1. The PCR amplification product and a DNA fragment that was obtained by treating a pDZ-hom vector with a Spel restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-hom-PaceA vector. SEQ ID NO: 21: PaceA-h3F 5'- gaggcggatcactagtagcactctgactacctctg -3' SEQ ID NO: 22: PaceA-h3R 5'- aagggactaaactagtttcctgtgcggtacgtggc -3'
Example 9: Pre parate ion of Strains to Which aceA Gene Promoter is Inserted Downstream of horn Gene and Comparison of Lvsine Productivity thereof [0092] The Corynebacterium glutamicum KCCM11016P that is an L-lysine-producing strain was transformed with the pDZ-hom-PaceA vector prepared in Example 8 by the same method as Example 3. The strain in which an aceA gene promoter was inserted downstream of the horn gene stop codon on the chromosome so that the transcription may occur in a direction opposite to the original direction of the horn gene transcription was selected by performing a PCR to obtain an L-lysine-producing strain, which was named as KCCM11016P::hom-PaceA. The prepared KCCM11016P::hom-PaceA strain was verified that the nucleotide sequence of target region obtained was analyzed by performing a PCR using SEQ ID NO: 17 and SEQ ID NO: 20 as primers.
[0093] T h e Corynebacterium glutamicum KCCM11016P strain which was used as a parent strain and the prepared KCCM11016P::hom-PaceA strain were cultured by the same method as Example 4, and the concentration of L-lysine recovered from the culture solutions was measured. When acetate was not added, the L-lysine concentration in the culture solutions of the Corynebacterium glutamicum KCCM11016P strain and the KCCM11016P::hom-PaceA is shown in Table 7.
Table 7. Variation of L-lysine production (acetate not added)
[0094] In addition, the strains were cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-lysine production. The L-lysine concentration in the culture solutions is shown in Table 8.
Table 8. Variation of L-lysine production (5 g/L of acetate added)
[0095] As shown in Table 7, in the absence of acetate, the L-lysine productivity of the KCCM11016P::hom-PaceAstrain was not different from that of the parent strain KCCM11016P.
[0096] However, as shown in Table 8, in the presence of acetate, the L-lysine productivity of the KCCM11016P::hom-PaceA strain was over 2.6% higher than that of the parent strain KCCM11016P.
Example 10: Preparation of Vector for Inhibiting murE Gene Expression [0097] UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase (murE, NCgl2083) uses meso-2,6-diaminopimelate, which is a precursor for lysine biosynthesis, in somatic synthesis. Weakening of the murE gene activity may decrease the inflow of carbon sources to somatic synthesis and increase the inflow of carbon sources to a lysine biosynthetic pathway to increase lysine production.
[0098] In Corynebacterium glutamicum, the murE gene (NCgl2083) forms an operon with seven genes from NCgl2076 to NCgl2082. The transcription of the operon starts from the NCgl2083 murE in the direction of the NCgl2076 gene. So, a transcription terminator exists downstream of the NCg 12076 gene. Therefore, an aceAgene promoter was inserted downstream of the murE gene stop codon so that the transcription may occurin a direction opposite to the original direction of the murE gene transcription in order to selectively inhibit the expression of the murE gene in the presence of acetate. To maintain the expression of the other seven genes except the murE gene which is located in the first region of the operon, a murE operon promoter was further added upstream of the NCgl2082 gene ORF.
[0099] In Example 10, a recombinant vector was prepared by inserting an aceAgene promoter downstream of the murE gene stop codon.
[0100] To obtain a fragment of a Corynebacterium glutamicum-derived murE gene, the chromosomal DNAof Corynebacterium glutamicum KCCM11016P was used as a template, and primers, which were designed to have an Xbal restriction enzyme recognition site at a 5' end of the fragment and an Xhol restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 23 and 24), were synthesized. A PCR was performed using the synthesized primers to obtain a DNAfragment including 300 base pairs between the 1267th nucleotide from the murE gene start codon and the 1566th nucleotide which was a stop codon. In addition, primers, which were designed to have an Xhol restriction enzyme recognition site at a 5' end of the fragment and an Xbal restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 25 and 26), were synthesized. A PCR was performed using the synthesized primers to obtain a DNA fragment including 292 base pairs from the 10th nucleotide downstream of the murE gene stop codon. The PCR was performed under the same conditions as Example 2. The two PCR amplification products and a pDZ vector for chromosomal introduction that had already been prepared by cleaving with an Xbal restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-murE vector. SEQ ID NO: 23: mur-m1 F 5'- ccggggatcctctagaaaccctcgttcagaggtgc -3' SEQ ID NO: 24: mur-m1 R 5'- ttgtgatcatctcgagctatccttcttccgtagtaag -3' SEQ ID NO: 25: mur-m2F 5'- ag ctcgagatgatcacaatgacccttgg -3' SEQ ID NO: 26: mur-m2R 5'- gcaggtcgactctagacatgagcataaatgtcagc -3' [0101] To obtain a fragment of a Corynebacterium giutarncum-demed aceAgene, primers, which were designed to have an Xhol restriction enzyme recognition site at a 5' end of the fragment (SEQ ID NOs: 27 and 28), were synthesized. The chromosomal DNA of Corynebacterium glutamicum KCCM11016P as a template, and the synthesized primers were used to perform a PCR to amplify a promoter region of about 500 base pairs being represented by a base sequence of SEQ ID NO: 1. In addition, to obtain a promoter region of a Corynebacterium giutamicum-demed murE operon, the chromosomal DNA of Corynebacterium glutamicum KCCM11016P was used as a template, and primers, which were designed to have an Xhol restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 29 and 30), were synthesized. A PCR was performed using the synthesized primers to obtain a DNA fragment including 300 base pairs upstream of murE gene ORF.
[0102] The two PCR amplification products and the DNA fragment obtained by treating the pDZ-murE vector with Xhol restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-murE-PaceA-PmurE vector. SEQ ID NO: 27: mur-m3F 5'- tcatcagcagcactctgactacctctg -3' SEQ ID NO: 28: mur-m3R 5'- agaaggatagctcgagttcctgtgcggtacgtggc -3' SEQ ID NO: 29: mur-m4F 5'- agagtgctgctgatgatcctcgatttg -3' SEQ ID NO: 30: mur-m4R 5'- ttgtgatcatctcgagggttttctctcctccacagg -3'
Example 11: Preparation of Strains to Which aceA Gene Promoter is Inserted Downstream of murE Gene and Comparison of Lvsine Productivity thereof [0103] The Corynebacterium glutamicum KCCM11016P was transformed with the pDZ-murE-PaceA-PmurEvector prepared in Example 10 by the same method as Example 3.
[0104] The strain in which an aceA gene promoter was inserted downstream of the murE gene stop codon on the chromosome so that the transcription may occur in a direction opposite to the original direction of the murE gene transcription was selected by performing a PCR to obtain an L-lysine-producing strain, which was named as KCCM11016P::murE-PaceA-PmurE. The prepared KCCM11016P::murE-PaceA-PmurE strain was verified that the nucleotide sequences of target region obtained was analyzed by performing a PCR using SEQ ID NO: 23 and SEQ ID NO: 26 as primers.
[0105] The Corynebacterium glutamicum KCCM11016P strain which was used as a parent strain and the prepared KCCM11016P::murE-PaceA-PmurE strain were cultured by the same method as Example 4, and the concentration of L-lysine recovered from the culture solutions was measured. When acetate was not added, the L-lysine concentration in the culture solutions of the Corynebacterium glutamicum KCCM11016P strain and the KCCM11016P::murE-PaceA-PmurE strain is shown in Table 9.
Table 9. Variation of L-lysine production (acetate not added)
[0106] In addition, the strains were cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-lysine production The L-lysine concentration in the culture solutions is shown in Table 10.
Table 10. Variation of L-lysine production (5 g/L of acetate added)
[0107] As shown in Table 9, in the absence of acetate, the L-lysine productivity of the KCCM11016P::murE-PaceA-PmurE strain was not different from that of the parent strain KCCM11016P.
[0108] However, as shown in Table 10, in the presence of acetate, the L-lysine productivity of the KCCM11016P::murE-PaceA-PmurE strain was over 2.8% higher than that of the parent strain KCCM11016P.
Example 12: Preparation of Vector for Inhibiting dapAGene Expression [0109] L-lysine biosynthetic pathway using the same substrate as L-threonine biosynthetic pathway may be weakened to increase L-threonine productivity. An example of the methods of weakening L-lysine biosynthetic pathway is to decrease the enzymatic activity of dihydrodipicolinate synthase (dapA, NCgl1896) which is involved in the production of lysine from aspartate.
[0110] In Corynebacterium glutamicum, the dapA gene forms dapA-ORF4 operon with ORF4 (NCgl1895) gene, and thus the transcription terminator of the dapA gene exists downstream of the ORF4 gene. In addition, it was reported that a promoter exists upstream of the dapA-ORF4 operon that is upstream of the dapA gene, and a second promoter exists upstream of the ORF4 gene (Patek et al., Biotechnology letters, 19:1113-1117, 1997 ). Therefore, an aceA gene promoter was inserted downstream of the dapA gene stop codon so that the transcription may occur in a direction opposite to the original direction of the dapA gene transcription in order to selectively inhibit the expression of the dapAgene in the presence of acetate. To maintain the expression of the ORF4 gene, a promoter region sequence of about 100 base pairs in the ORF4 gene upstream was added to the ORF upstream of the ORF4 gene.
[0111] In Example 12, a recombinant vector was prepared by inserting an aceA gene promoter downstream of the dapAgene stop codon.
[0112] To obtain a fragment of a Corynebacterium glutamicum-demed dapA gene, the chromosomal DNA of Corynebacterium glutamicum KCCM11016P was used as a template, and primers, which were designed to have an Xbal restriction enzyme recognition site at a 5' end of the fragment and an Spel restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 31 and 32), were synthesized. A PCR was performed using the synthesized primers to obtain a DNA fragment including 301 base pairs between the 606th nucleotide from the dapA gene start codon and the 906th nucleotide which was a stop codon. In addition, primers, which were designed to have an Spel restriction enzyme recognition site at a 5' end of the fragment and an Xbal restriction enzyme recognition site at a 3' end of the fragment (SEQ ID NOs: 33 and 34), were synthesized. Through a PCR, a DNA fragment which further includes a promoter region sequence of about 100 base pairs between the 809th nucleotide from the dapA gene start codon and the 2nd nucleotide in the stop codon downstream, to maintain the expression of the ORF4 gene, and 213 base pairs in the dapA gene stop codon downstream was obtained. The PCR was performed under the same conditions as Example 2. The two PCR amplification products and a pDZ vector for chromosomal introduction that had already been prepared by cleaving with an Xbal restriction enzyme were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-dapA vector. SEQ ID NO: 31: dapA-d1 F 5'- ccggggatcctctaga tgtttggcttgctttgggc-31 SEQ ID NO: 32: dapA-d1 R 5'- gttgatgcactagtttatagaactccagcttt-3' SEQ ID NO: 33: dapA-d2F 5'- ttctataaactagtgcatcaacgtaggagatcc -3' SEQ ID NO: 34: dapA-d2R 5'- gcaggtcgactctagacgttctgggaaccctgag -3' [0113] To obtain a promoter fragment of a Corynebacterium glutamicum-demed aceA gene, primers, which were designed to have an Spel restriction enzyme recognition site at a 5' end and at a 3' end of the fragment (SEQ ID NOs: 35 and 36), were synthesized. The PCR was performed using the chromosomal DNA of Corynebacterium glutamicum KCCM11016P as a template and the synthesized primers to amplify a promoter region of about 500 base pairs being represented by a nucleotide sequence of SEQ ID NO: 1. The PCR amplificated product and a DNA fragment,which was obtained by treating a pDZ-dapA vector with a Spel restriction enzyme, were cloned by using an In-fusion Cloning Kit (TAKARA, JP) to prepare a pDZ-dapA-PaceA vector. SEQ ID NO: 35: PaceA-d3F 5'- acgttgatgc actagt agcactctgactacctctg -3' SEQ ID NO: 36: PaceA-d3R 5'- agttctataa actagt ttcctgtgcggtacgtggc -3'
Example 13: Preparation of Strains in Which aceA Gene Promoter is Inserted Downstream of dapA Gene and Comparison of Threonine Productivity thereof [0114] To verify the effect of inhibiting the dapA gene expression in an L-threonine-produdng strain, the pDZ-dapA-PaceA vector prepared in Example 12 was transformed by the same method as Example 3 into a Corynebacterium glutamicum KCCM11222P (Korean Patent NO: 2013-0061570) strain that is an L-threonine-producing strain. The strain in which an aceA gene promoter was inserted downstream of the dapA gene stop codon on the chromosome so that the transcription may occur in a direction opposite to the original direction of the dapA gene transcription was selected by performing a PCR, which was named as KCCM11222P::dapA-PaceA. The prepared KCCM11222P::dapA-PaceA strain was verified that the nucleotide sequence of target region obtained was analyzed by performing a PCR by using SEQ ID NO: 31 and SEQ ID NO: 34 as primers.
[0115] The Corynebacterium glutamicum KCCM11222P strain, which was used as a parent strain, and the prepared KCCM11222P::dapA-PaceA strain were cultured by the method described below.
[0116] Each of the strains was respectively inoculated 25 ml of a seed medium in 250 ml corner-baffled flasks, followed by shaking culture at 200rpm at 30 °C for 20 hours. Afterward, 1 ml of the seed culture solution was added to a 250 ml corner-baffled flask including 24 ml of a production medium, followed by shaking culture at 200rpm at 30 °C for 48 hours at 200 rpm. The respective compositions of the seed medium and the production mediums are described below. <Seed medium (pH 7.0)> [0117] glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSC>4*7(H2C>) 0.5 g, biotin 100 pg, thiamine HC11000 pg, calcium pantothenate 2000 pg, nicotinamide 2000 pg (with reference to 1 L of distilled water). «Production medium (pH 7.0)> [0118] glucose 100 g, (NH4)2SC>4 20 g, soy protein 2.5 g, corn steep solids 5 g, urea 3 g, KH2PO4 1 g, MgSC>4*7(H2C>) 0.5 g, biotin 100 pg, thiamine HCI 1000 pg, calcium pantothenate 2000 pg, nicotinamide 3000 pg, CaCC>3 30 g (with reference to 1 L of distilled water).
[0119] After the culturing, L-threonine concentration in the culture solution was measured by HPLC. When acetate was not added, the L-threonine concentration in the culture solutions of Corynebacterium glutamicum KCCM11222P and KCCM11222P::dapA-PaceAis shown in Table 11.
Table 11. Variation of L-threonine production (acetate not added)
[0120] In addition, the strains were cultured by the same method except that 5 g/L of acetate was added to the production medium to compare the L-threonine production. The L-threonine concentration in the culture solutions is shown in Table 12.
Table 12. Variation of L-threonine production (5 g/L of acetate added)
[0121] As shown in Table 11, in the absence of acetate, the L-threonine productivity of the KCCM11222P::dapA-PaceA strain was not different from that of the parent strain KCCM11222P.
[0122] However, as shown in Table 12, in the presence of acetate, the L-threonine productivity of the KCCM11222P::dapA-PaceA strain was over 50% higher than that of the parent strain KCCM11222P.
[Accession Number] [0123]
Research Center Name: Korean Collection for Type Cultures (International)
Accession Number: KCCM11432P Accession Date: June 12, 2013 [0124] As described above, according to the one or more of the above embodiments of the present invention, an acetate-inducible promoter may be used to effectively produce L-amino acids, since a target L-amino acid may be produced in a high yield by weakening the expression of a target gene by adding acetate at an appropriate time.
[0125] While one or more embodiments of the present invention have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the scope of the present invention as defined by the following claims. <110> CJ CheilJedang Corporation <120> Method of producing L-amino acids
<130> PX047465OV <150> KR 2013/0121090 <151> 2013-10-11 <150=* KR 2014/0091307 <151> 2014-07-19 <160> 36 <170> Kopatentln 2.0
<210> 1 <211 > 522 <212> DNA <213> Corynebacterium glutamicum <220> <221> gene <222> (1)..(486)
<223> aceA <400> 1 agcactctga ctacctctgg aatctaggtg ccactcttct ttcgatttca acccttatcg 60 tgtttggcga tgtgatcaga ctaagtgatc accgtcacca gcaaaagggg tttgcgaact 120 ttactaagtc attacccccg cctaaccccg acttttatct aggtcacacc ttcgaaacct 180 acggaacgtt gcggtgcctg cattttccca tttcagagca tttgcccagt acatccgtac 240 tagcaactcc cccgcccact ttttctgcga agccagaact ttgcaaactt cacaacaggg 300 gtgaccaccc ccgcacaaaa cttaaaaacc caaaccgatt gacgcaccaa tgcccgatgg 360 agcaatg-tgt gaaccacgcc accacgcaaa ccgatgcaca tcacgtcgaa acagtgacag 420 tgcattagct catactttgt ggtcggcacc gcccattgcg aatcagcact taaggaagtg 480 actttgatgt caaacgttgg aaagccacgt accgcacagg aa 522
<210> 2 <211> 340 <212> DNA <213> Corynebacterium glutamicum <220> <221 > gene <222> (1)..(340) <223> pta <400> 2 ctttgctggg gtcagatttg tcacgctgcg cgctttcata gaccccatta atggggggtg 60 aagagctgta aagtaccgct aaaaactttg caaagggtgc ttcgcaactt gtaaccgctc 120 cgtattgttt tctacggcaa taagcatttg tgctgctcaa agcgtggaat tgagatcggt 180 ttgaaaatta caaaataaaa ctttgcaaac cgggctgtac gcaaggcgga cgaacgctaa 240 actatgtaag aaatcacaac ctcccctcat tagtgccagg aggcacaagc ctgaagtgtc 300 atcaatgaga aggttcaggc tgaaattaga aaggcgatgt 340 <210> 3 <211> 35
<212> DNA <213> Artificial Sequence <220> <223> aceE P1F <400>3 ccggggatcc tctagacctc cggcccatac gttgc 35
<210> 4 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> aceE P1R <400> 4 ttgagactag ttattcctca ggagcgtttg 30
<210>5 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> aceE P2F <400>5 gaataactag tctcaaggga cagataaatc 30
<210> 6 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> aceE P2R <400>6 gcaggtcgac tctagagacc gaaaagatcg tggcag 36
<210>7 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA P3F <400>7 gtcccttgag actagtagca ctctgactac ctctg 35
<210> 8 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA P3R <400>8 ctgaggaata actagtttcc tgtgcggtac gtggc 35
<210> 9 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> aceE P4F <400>9 ccggggatcc tctagaggtc ccaggcgact acacc 35
<210> 10 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> aceE P4R <400> 10 gagctactag tacgacgaat cccgccgcca gacta 35
<210> 11 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> aceE P5F <400> 11 gtcgtactag tagctctttt tagccgagga acgcc 35
<210> 12 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> aceE P5R <400> 12 gcaggtcgac tctagacatg ctgttggatg agcac 35
<210> 13 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA P6F <400> 13 aaaaagagct actagtagca ctctgactac ctctg 35
<210> 14 <211> 35 <212> DNA <213> Artificial Sequence <220>
<223> PaceA P6R <400> 14 gattcgtcgt actagtttcc tgtgcggtac gtggc 35
<210> 15 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> Ppta P7F <400> 15 gtcccttgag actagtcttt gctggggtca gatttg 36
<210> 16 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> Ppta P7R <400> 16 ctgaggaata actagtacat cgcctttcta atttc 35
<210> 17 <211 => 35 <212> DNA <213> Artificial Sequence <220> <223> hom h1F <400> 17 ccggggatcc tctagaccag gtgagtccac ctacg 35
<210> 18 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> hom h1R <400> 18 gaggcggatc actagtttag tccctttcga ggcgg 35
<210> 19 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> hom h2F <400> 19 actagtgatc cgcctcgaaa gggac 25
<210>20 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> horn h2R <400> 20 gcaggtcgac tctagagact gcggaatgtt gttgtg 36
<210> 21 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA h3F <400> 21 gaggcggatc actagtagca ctctgactac ctctg 35
<210> 22 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA h3R <400> 22 aagggactaa actagtttcc tgtgcggtac gtggc 35
<210> 23 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> mur m1F <400> 23 ccggggatcc tctagaaacc ctcgttcaga ggtgc 35
<210> 24 <211> 37 <212> DNA <213> Artificial Sequence <220> <223> mur m1R <400> 24 ttgtgatcat ctcgagctat ccttcttccg tagtaag 37
<210> 25 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> mur m2F <400> 25 agctcgagat gatcacaatg acccttgg 28 <210> 26 <211> 35
<212> DNA <213> Artificial Sequence <220> <223> mur m2R <400> 26 gcaggtcgac tctagacatg agcataaatg tcagc35
<210> 27 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> mur m3F <400> 27 tcatcagcag cactctgact acctctg 27
<210> 28 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> mur m3R <400> 28 agaaggatag ctcgagttcc tgtgcggtac gtggc 35
<210> 29 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> mur m4F <400> 29 agagtgctgc tgatgatcct cgatttg 27
<210> 30 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> mur m4R <400> 30 ttgtgatcat ctcgagggtt ttctctcctc cacagg 36
<210> 31 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> dapA d1 F <400> 31 ccggggatcc tctagatgtt tggcttgctt tgggc 35
<210> 32 <211>32 <212> DNA <213> Artificial Sequence <220> <223> dapAdIR <400> 32 gttgatgcac tagtttatag aactccagct tt 32
<210> 33 <211> 33 <212> DNA <213> Artificial Sequence <220> <223> dapA d2F <400> 33 ttctataaac tagtgcatca acgtaggaga tcc 33
<210> 34 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> dapA d2R <400> 34 gcaggtcgac tctagacgtt ctgggaaccc tgag 34
<210> 35 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceAd3F <400> 35 acgttgatgc actagtagca ctctgactac ctctg 35
<210> 36 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> PaceA d3R <400> 36 agttctataa actagtttcc tgtgcggtac gtggc 35
REFERENCES CITED IN THE DESCRIPTION
This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.
Patent documents cited in the description • KR100159812 [0032] • KRt 00924065 Γ0032Ί [00541 • KBJ.MQZ3610 .[0032]. . KR101335853 Γ00341 • KR20130061570 [0114] • KR2Q130121090 [01251 • KR20140091307 [01251
Non-patent literature cited in the description • KRYLOV et al.J Mol Microbiol Biotechnol, 2010, vol. 18, 1-13 [0003] . GERSTMEIRet al.J Biotechnol, 2003, vol. 104, 99-122 [00121 [00471 . BINDER et al.Genome Biology, 2012, vol. 13, R40- [00331 • Manual of Methods for General BacteriologyAmerican Society for Bacteriologyl 9810000 [0037] • BLOMBACH et al.AppI Microbiol Biotechnol, 2007, vol. 76, 3615-23 [00491 . VAN DER RESTet al.AppI Microbiol Biotechnol, 1999, vol. 52, 541-545 [S0S0] • MATEOS et al.J Bacteriol, 1994, vol. 176, 7362-7371 [00871 • PATEKetal.Biotechnology letters, 1997, vol. 19, 1113-1117 [01101
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130121090 | 2013-10-11 | ||
KR1020140091307A KR101518860B1 (en) | 2013-10-11 | 2014-07-18 | Method for producing L-amino acid |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2860256T3 true DK2860256T3 (en) | 2017-06-06 |
Family
ID=53035683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14186238.3T DK2860256T3 (en) | 2013-10-11 | 2014-09-24 | Process for Preparation of L-Amino Acids |
Country Status (16)
Country | Link |
---|---|
JP (3) | JP6291042B2 (en) |
KR (1) | KR101518860B1 (en) |
CN (1) | CN104561163B (en) |
AR (1) | AR097977A1 (en) |
AU (2) | AU2014332732B2 (en) |
BR (1) | BR112016008029A2 (en) |
CA (1) | CA2925659C (en) |
DK (1) | DK2860256T3 (en) |
ES (1) | ES2626048T3 (en) |
GE (1) | GEP20196943B (en) |
JO (1) | JO3255B1 (en) |
MY (1) | MY172463A (en) |
PH (1) | PH12016500640A1 (en) |
PL (1) | PL2860256T3 (en) |
RU (2) | RU2614258C2 (en) |
UA (1) | UA117935C2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101518860B1 (en) * | 2013-10-11 | 2015-05-12 | 씨제이제일제당 (주) | Method for producing L-amino acid |
CN105734004B (en) * | 2016-03-02 | 2020-06-19 | 廊坊梅花生物技术开发有限公司 | Recombinant strain and preparation method and application thereof |
KR101925930B1 (en) * | 2017-07-24 | 2019-02-26 | 씨제이제일제당 주식회사 | Microorganisms producing L-lysine and process for producing L-lysine using the same |
CA3073607C (en) * | 2018-03-09 | 2023-07-04 | Cj Cheiljedang Corporation | A novel promoter and a method for producing l-amino acid using the same |
KR102221040B1 (en) * | 2019-05-09 | 2021-03-03 | 씨제이제일제당 주식회사 | Microorganism producing L-amino acid and method of producing Method of L-amino acid using thereof |
KR102134418B1 (en) * | 2019-06-17 | 2020-07-16 | 씨제이제일제당 주식회사 | A microorganism producing L-tyrosine and a method for producing L-tyrosine using thereof |
KR102207867B1 (en) * | 2020-01-21 | 2021-01-26 | 씨제이제일제당 주식회사 | Method for producing L-amino acids using microorganisms containing NADP dependent glyceraldehyde-3-phosphate dehydrogenase |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6649379B1 (en) * | 1987-06-12 | 2003-11-18 | Massachusetts Institute Of Technology | Method and deregulated enzyme for threonine production |
JP3036912B2 (en) * | 1991-09-02 | 2000-04-24 | 協和醗酵工業株式会社 | Gene expression regulatory DNA |
JP3783065B2 (en) * | 1994-03-04 | 2006-06-07 | 味の素株式会社 | Method for producing L-lysine |
HU222503B1 (en) * | 1995-06-07 | 2003-07-28 | Ajinomoto Co., Inc. | Process for producing l-lysine |
ATE263246T1 (en) * | 1999-02-20 | 2004-04-15 | Degussa | METHOD FOR THE FERMENTATIVE PRODUCTION OF L-AMINO ACIDS USING CORYNEFORMER BACTERIA |
JP4306169B2 (en) * | 1999-12-24 | 2009-07-29 | 味の素株式会社 | L-amino acid production method and novel gene |
AU2002230431A1 (en) * | 2000-11-15 | 2002-05-27 | Archer-Daniels-Midland Company | Corynebacterium glutamicum promoters |
KR100397423B1 (en) * | 2001-02-13 | 2003-09-13 | 씨제이 주식회사 | Process for producing L-threonine |
DE10224088A1 (en) * | 2002-05-31 | 2003-12-11 | Degussa | Process for the production of L-amino acids using coryneform bacteria which contain an attenuated mez gene |
JP2004261150A (en) * | 2003-03-04 | 2004-09-24 | Ajinomoto Co Inc | Method for producing objective material |
JP2005006564A (en) | 2003-06-19 | 2005-01-13 | Japan Tobacco Inc | Nitrate ion-inducing promoter |
JP2010226956A (en) * | 2007-07-23 | 2010-10-14 | Ajinomoto Co Inc | Method for producing l-lysine |
KR101335853B1 (en) | 2011-12-01 | 2013-12-02 | 씨제이제일제당 (주) | A microorganism having L-amino acids and riboflavin productivity and a method of producing L-amino acids and riboflavin using the same |
KR101518860B1 (en) * | 2013-10-11 | 2015-05-12 | 씨제이제일제당 (주) | Method for producing L-amino acid |
-
2014
- 2014-07-18 KR KR1020140091307A patent/KR101518860B1/en active IP Right Grant
- 2014-08-10 UA UAA201603717A patent/UA117935C2/en unknown
- 2014-09-24 DK DK14186238.3T patent/DK2860256T3/en active
- 2014-09-24 PL PL14186238T patent/PL2860256T3/en unknown
- 2014-09-24 ES ES14186238.3T patent/ES2626048T3/en active Active
- 2014-10-08 CA CA2925659A patent/CA2925659C/en active Active
- 2014-10-08 BR BR112016008029A patent/BR112016008029A2/en not_active Application Discontinuation
- 2014-10-08 JP JP2016521791A patent/JP6291042B2/en active Active
- 2014-10-08 RU RU2015151124A patent/RU2614258C2/en active
- 2014-10-08 GE GEAP201414125A patent/GEP20196943B/en unknown
- 2014-10-08 RU RU2016110804A patent/RU2651461C2/en active
- 2014-10-08 AU AU2014332732A patent/AU2014332732B2/en active Active
- 2014-10-08 MY MYPI2016701087A patent/MY172463A/en unknown
- 2014-10-09 JO JOP/2014/0287A patent/JO3255B1/en active
- 2014-10-09 AR ARP140103766A patent/AR097977A1/en unknown
- 2014-10-11 CN CN201410654216.XA patent/CN104561163B/en active Active
-
2016
- 2016-04-07 PH PH12016500640A patent/PH12016500640A1/en unknown
-
2017
- 2017-12-07 AU AU2017272295A patent/AU2017272295B2/en active Active
-
2018
- 2018-02-08 JP JP2018021175A patent/JP6824918B2/en active Active
-
2020
- 2020-01-24 JP JP2020009563A patent/JP2020078312A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2020078312A (en) | 2020-05-28 |
AU2017272295B2 (en) | 2019-05-16 |
KR20150042692A (en) | 2015-04-21 |
JP6824918B2 (en) | 2021-02-03 |
JO3255B1 (en) | 2018-09-16 |
PH12016500640B1 (en) | 2016-05-30 |
BR112016008029A2 (en) | 2017-10-03 |
MY172463A (en) | 2019-11-26 |
AU2017272295A1 (en) | 2018-01-04 |
UA117935C2 (en) | 2018-10-25 |
CN104561163A (en) | 2015-04-29 |
CN104561163B (en) | 2018-11-06 |
RU2016110804A (en) | 2016-07-27 |
JP2018113966A (en) | 2018-07-26 |
PL2860256T3 (en) | 2017-08-31 |
CA2925659C (en) | 2018-10-23 |
CA2925659A1 (en) | 2015-04-16 |
JP2016532439A (en) | 2016-10-20 |
RU2015151124A (en) | 2016-06-27 |
AU2014332732A1 (en) | 2016-04-21 |
KR101518860B1 (en) | 2015-05-12 |
AR097977A1 (en) | 2016-04-20 |
ES2626048T3 (en) | 2017-07-21 |
AU2014332732B2 (en) | 2017-12-07 |
JP6291042B2 (en) | 2018-03-14 |
RU2651461C2 (en) | 2018-04-19 |
RU2614258C2 (en) | 2017-03-24 |
PH12016500640A1 (en) | 2016-05-30 |
GEP20196943B (en) | 2019-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2860256T3 (en) | Process for Preparation of L-Amino Acids | |
JP6297134B2 (en) | Microorganism having putrescine productivity and putrescine production method using the same | |
JP6476212B2 (en) | Microbe of Corynebacterium that produces L-arginine and method for producing L-arginine using the same | |
KR20130072183A (en) | Method of producing l-lysine using microorganism having ability to produce l-lysine | |
EP2975114A1 (en) | Strain having enhanced l-valine productivity and l-valine production method using the same | |
US9758771B2 (en) | Microorganism with enhanced L-lysine productivity and method for producing L-lysine by using same | |
JP6465997B2 (en) | Gluconate repressor mutant, microorganism producing L-lysine containing the same, and method for producing L-lysine using the same | |
US10801048B2 (en) | Method of producing L-amino acids | |
JP2019030316A (en) | Microorganism having activity for producing l-lysine and producing method of l-lysine using the same | |
JP6526058B2 (en) | Corynebacterium genus microorganism which produces L-lysine, and method of producing L-lysine using the same | |
RU2697005C2 (en) | Method of producing l-amino acids | |
JP6936343B2 (en) | New polypeptide and method for producing ornithine products using it | |
US20170247727A1 (en) | Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same | |
EP3255150A1 (en) | Microorganism capable of producing quinolinic acid, and method for producing quinolinic acid utilizing the microorganism |